BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
基本信息
- 批准号:10696603
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAmericanAreaAutoimmune DiseasesAwardBasic ScienceBiological SciencesBrain InjuriesCause of DeathCell DeathCell Differentiation processCellsCessation of lifeChronicClinicalClinical ResearchCollaborationsCommunicationDevelopmentDiseaseDoctor of MedicineDoctor of PhilosophyEducationEuropeanFacultyFailureFunctional disorderFundingGoalsGovernmentGrant ReviewHealthHealthcareHealthcare SystemsHemorrhageHepatologyIACUCImmunologyInfectionInflammationInstitutionInternationalInterventionJournalsLaboratoriesLiteratureMedicalMedicineMentorsMolecularNatural ImmunityNatureOperative Surgical ProceduresOrganPaperPathogenesisPatientsPeer ReviewPharmaceutical PreparationsPhasePhysiciansPlayPostdoctoral FellowPrincipal InvestigatorProductivityPublicationsPublishingReportingResearchResearch PersonnelResearch Project GrantsReview CommitteeRoleScienceScientistSepsisSignal TransductionSpinal InjuriesStrokeStudy SectionSystemic Inflammatory Response SyndromeTherapeutic InterventionTimeTraumaTrauma patientUnited States National Institutes of HealthUniversitiesVeteransWorkcareercareer developmentclinical investigationeditorialfrontierhuman diseasemembermilitary veteranmortalitynew therapeutic targetnovelpatient populationpeerpost-traumapreventpreventive interventionprogramsprophylacticsenior facultyseptic patientssurgical researchsymposiumtherapy developmentvisiting scholar
项目摘要
PROJECT SUMMARY
Jie Fan, M.D., M.Sc. has been working in the VA Pittsburgh Healthcare System (VAPHS) since
2003 and is a VA Research Career Scientist, a Director of the Surgical Research Program, a Vice-
Chair of the Institutional Animal Care and Use Committee, a Mentor of VA Career Development
Awardees at VAPHS, and a tenured Full Professor of Surgery and Immunology in the Departments of
Surgery and Immunology at the University of Pittsburgh. He is a Principal Investigator working on the
cellular and molecular mechanisms of post-trauma and post-sepsis systemic inflammatory response
syndrome (SIRS) and acute lung injury (ALI), an important but exceptionally difficult area. His
laboratory has been continuously funded by VA merit review grants since 2007 and NIH research
grants (R01, P50, and R56) since 2005.
The burden of trauma- and sepsis-related diseases is considerable in veterans. Following
exsanguination and/or brain injury that commonly result in early phase death, more than 60% of
surviving patients later die of causes related to the development of SIRS, sepsis, and ALI. This patient
population is well suited for prophylactic interventions aimed at preventing these occurrences because
of the time lag before the onset of organ inflammation and failure. Nonetheless, few specific targets
have been identified that predispose to SIRS and ALI. The long-term goal of Dr. Fan's studies is to
provide a new understanding of the mechanisms of post-trauma/post-infection inflammation and organ
dysfunction and to develop novel preventive and therapeutic interventions in SIRS, sepsis, and ALI.
The studies by Dr. Fan's team will also provide a greater understanding of the pathogenesis of multiple
human diseases in which inflammation plays a central role.
ALI is one of the common endpoints of SIRS and sepsis. SIRS and sepsis are common causes of
mortality following surgery, infection, spinal injury, stroke, hemorrhage, and trauma in the veteran
population. And thus, Dr. Fan's research is highly relevant to veterans' health.
Dr. Fan is a highly productive Principal Investigator with a long track record of both VA and NIH
funding. He has also served in roles such as Co-Investigator, Consultant, and Collaborator on
numerous other's research grants. His research and collaborations have resulted in 136 peer-reviewed
publications, many of them in the first-line scientific journals, including Nature Medicine, Nature
Communications, Journal of Clinical Investigation, Hepatology, Journal of Hepatology, Cell Death &
Differentiation, and Journal of Immunology. Dr. Fan's work is renowned by his peers nationally and
internationally. He has been an invited speaker at numerous national and international conferences and
at many research and educational institutions. He serves as a regular or Ad Hoc member in a number
of national peer-review committees, including NIH, VA, DoD, American Institution of Biological Sciences
study sections, and European scientific institutions. He also serves as an editor-in-chief, member of
editorial board, and invited reviewer for over 50 scientific journals.
He has mentored 33 VA and VA WOC trainees including VA Career Development Awardee,
surgery residents, Ph.D. candidates, postdoctoral fellows, and visiting scholars, many of whom have
now become independent scientists or physician-scientists.
项目摘要
Jie Fan,医学博士,一直在VA匹兹堡医疗保健系统(VAPHS)工作,
2003年,是VA研究职业科学家,外科研究项目主任,副主任,
机构动物护理和使用委员会主席、VA职业发展导师
VAPHS的获奖者,以及外科和免疫学系的终身教授,
匹兹堡大学的外科学和免疫学。他是一名首席研究员,
创伤和脓毒症后全身炎症反应的细胞和分子机制
综合征(SIRS)和急性肺损伤(ALI),这是一个重要但异常困难的领域。他
自2007年以来,一个实验室一直得到退伍军人事务部优秀评审补助金的资助,
自2005年以来,获得了R01、P50和R56赠款。
创伤和脓毒症相关疾病的负担在退伍军人中相当大。以下
通常导致早期死亡的失血和/或脑损伤,超过60%的
存活的患者后来死于与SIRS、脓毒症和ALI的发展相关的原因。该患者
人群非常适合预防性干预措施,目的是防止这些事件的发生,
器官炎症和衰竭发生前的时间差。尽管如此,
已被确定易患SIRS和ALI。范博士研究的长期目标是
为创伤后/感染后炎症和器官损伤的机制提供了新的认识。
本研究的目的是开发SIRS、脓毒症和ALI的新型预防和治疗干预措施。
Fan博士团队的研究还将更好地了解多发性骨髓瘤的发病机制。
炎症在其中起核心作用的人类疾病。
ALI是SIRS和脓毒症的共同终点之一。SIRS和脓毒症是常见的原因
退伍军人手术、感染、脊髓损伤、中风、出血和创伤后的死亡率
人口因此,范博士的研究与退伍军人的健康高度相关。
Fan博士是一位高效的首席研究员,在VA和NIH都有长期的工作记录。
经费他还担任过以下职务:
许多其他的研究经费。他的研究和合作导致了136个同行评审
出版物,其中许多是在一线科学期刊,包括自然医学,自然
通讯,临床研究杂志,肝病学,肝病学杂志,细胞死亡与
分化和免疫学杂志。范博士的工作在全国同行中享有盛誉,
化国际大他曾应邀在许多国家和国际会议上发言,
在许多研究和教育机构。他在一些组织中担任正式成员或临时成员,
国家同行评审委员会,包括NIH、VA、DoD、美国生物科学研究所
研究部门和欧洲科学机构。他还担任主编,
编辑委员会和50多种科学期刊的特邀评审员。
他指导了33名VA和VA WOC学员,包括VA职业发展奖获得者,
外科住院医生,博士候选人,博士后研究员和访问学者,其中许多人有
现在成为独立的科学家或医生科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jie Fan其他文献
Jie Fan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jie Fan', 18)}}的其他基金
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
ILC2 在脓毒症急性肺损伤中的调节作用
- 批准号:
10618774 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
ILC2 在脓毒症急性肺损伤中的调节作用
- 批准号:
9885001 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
ILC2 在脓毒症急性肺损伤中的调节作用
- 批准号:
10293529 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Macrophage Pyroptosis Mechanism of Post-Trauma Acute Lung Injury
创伤后急性肺损伤的巨噬细胞焦亡机制
- 批准号:
10260392 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Macrophage Pyroptosis Mechanism of Post-Trauma Acute Lung Injury
创伤后急性肺损伤的巨噬细胞焦亡机制
- 批准号:
9593050 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Aging-Related Mechanism of Post-Hemorrhagic Shock Acute Lung Injury
失血性休克后急性肺损伤的衰老相关机制
- 批准号:
9130376 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Cell Death Mechanism of Acute Lung Injury in Sepsis
脓毒症急性肺损伤的细胞死亡机制
- 批准号:
9275434 - 财政年份:2014
- 资助金额:
-- - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
-- - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship














{{item.name}}会员




